Growth Metrics

Lifevantage (LFVN) EPS (Weighted Average and Diluted) (2016 - 2026)

Lifevantage filings provide 16 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.02 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 89.47% to $0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.6, a 7.14% increase, with the full-year FY2025 number at $0.75, up 226.09% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.02 in Q4 2025 for Lifevantage, down from $0.17 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.35 in Q2 2021 to a low of -$0.11 in Q2 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.11 (2021), compared with a mean of $0.1.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 900.0% in 2022 and later surged 480.0% in 2024.
  • Lifevantage's EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then tumbled by 900.0% to -$0.08 in 2022, then soared by 37.5% to -$0.05 in 2023, then soared by 480.0% to $0.19 in 2024, then tumbled by 89.47% to $0.02 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.02 (Q4 2025), $0.17 (Q3 2025), and $0.15 (Q2 2025) per Business Quant data.